Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation
Clinical trial NCT06444087 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06444087
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-17
- Primary completion
- 2027-06-30
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.